Choosing a brdu antibody and the DNA damage reagents beside it: why nucleotide incorporation needs a denaturation step no other stain requires, what a par antibody reports about damage signalling, and the controls that separate incorporation from background

Making an incorporation stain work

1. Denature the DNA, or the antibody cannot reach the epitope. The incorporated nucleotide sits within double stranded DNA and is inaccessible. Acid treatment, heat or a nuclease step opens it, and without one the stain is blank. This single requirement accounts for most reported failures of these reagents.
2. Accept what the denaturation costs you. Acid denaturation damages protein epitopes and most fluorescent proteins, so a panel combining incorporation with surface or fluorescent protein markers has to be designed around it. Nuclease-based methods are gentler and are the route when other markers must survive.
3. Fix the pulse length before the experiment. The label marks cells that were synthesising during the pulse, so a short pulse measures a rate and a long one measures cumulative entry. Two studies with different pulse lengths are not comparable, and the length belongs in the methods.
4. Run an unlabelled control through the whole protocol. Cells that never saw the nucleotide, taken through denaturation and staining, show what the harsh protocol does to background. It is the control that matters most here and is routinely omitted.
5. Read damage signalling markers as a modification, not a level. Poly-ADP-ribose and related damage marks are generated transiently at damage sites, so the measurement is their appearance and their kinetics rather than a steady level. Include a known inducer and a time course, or the absence of signal means nothing.

Alternatives that avoid the denaturation entirely

Click chemistry detection of an alkyne-modified nucleotide needs no denaturation, preserves protein epitopes and fluorescent proteins, and is far easier to multiplex. It costs more per sample and has largely replaced the acid protocol where budget allows.

Where only the fraction of cycling cells is needed and the timing does not matter, an accumulation marker is cheaper and simpler. The incorporation method is bought for the timing, and if the timing is not the question it is the wrong tool.

Quantifying an index

Count against a nuclear counterstain as the denominator, fix the acquisition settings from a control and define the threshold before looking. An incorporation index is a fraction and the denominator has to be counted rather than estimated.

For cytometry, the incorporation signal against DNA content gives the cell cycle distribution directly, which is far more informative than a single positive fraction and costs one extra channel.

In vivo labelling

Dosing, route and clearance all change what an in vivo pulse labels, and the animal work brings its own approvals. Record the dose and the interval to collection with the data, because they define the window as much as the pulse length does in culture.

Toxicity of the label itself at high dose or long exposure is real and is worth checking against the literature for the model, particularly in developmental studies.

A fitc secondary antibody and where it still earns its place

A fitc secondary antibody is bright, cheap and photobleaches quickly, which is why it survives in routine immunofluorescence and not in quantitative imaging, where a more stable dye in the same channel is the sensible swap. Its emission overlaps several common dyes, so the panel rather than the conjugate decides whether it can be used at all. Mounting medium with an antifade agent extends it measurably.

A pe conjugated antibody and the brightness flow work needs

A pe conjugated antibody is bright because the fluorophore is a large protein complex, which is what makes it the workhorse for dim surface markers and what makes it unsuitable where the tag's size would block binding. It is sensitive to fixation and to light, and it spills into neighbouring channels, so compensation controls are part of the panel rather than an afterthought.

An apc conjugated antibody and the far red channel

An apc conjugated antibody sits in a channel away from cellular autofluorescence and away from PE, which is why the two are the usual first pair in a small panel. The conjugate is also a protein complex and is degraded by fixation over time, so stained samples are read promptly. Tandem dyes built on it drift as they degrade, which shows as a shifting population between runs.

An hrp labeled secondary antibody and the substrate that follows it

An hrp labeled secondary antibody is chosen with its substrate: a chemiluminescent one for a blot with a wide dynamic range, a chromogenic one for a section where a permanent record is wanted. Endogenous peroxidase in blood rich tissue is blocked before the antibody goes on. Signal is enzymatic and therefore time dependent, which is why exposure or development time belongs in the method.

secondary antibodies for western blot, and how one is chosen

Choosing secondary antibodies for western blot is a question about the host of the primary, the conjugate the detection system needs, and whether cross adsorption is required because more than one species is on the membrane. An anti-mouse raised in goat and cross adsorbed against rat is a different product from a plain anti-mouse. Dilution is titrated once and then kept, since it sets the background.

An elisa secondary antibody and the plate format's demands

An elisa secondary antibody works in a very different regime from a blot: the assay is quantitative, so lot to lot consistency and a low background matter more than absolute brightness, and the conjugate is usually an enzyme read as a rate. High affinity and low non specific binding to the plate are what the datasheet should evidence. A matched blocking buffer is part of the choice.

A capture antibody elisa pairing, and why the pair is sold together

In a capture antibody elisa the two antibodies must bind different epitopes at the same time, which is why matched pairs are sold and validated together rather than assembled from two catalogue clones. The capture antibody is coated and the detection antibody is labelled, and swapping them usually loses sensitivity. A standard curve in the same matrix as the samples is what makes the readout a concentration.

An xrcc1 antibody and the repair complex it scaffolds

XRCC1 has no enzymatic activity and works by holding repair enzymes together, so an xrcc1 antibody is read as recruitment to damage rather than as a level: laser or drug induced damage followed by focus formation is the experiment. That makes the imaging timing part of the method, since the foci resolve. A knockdown lane is what separates the band from a neighbouring protein.

Common questions

Why does my brdu antibody stain nothing?

Almost certainly the DNA was not denatured. The epitope is inside double stranded DNA and needs acid, heat or a nuclease step to expose it, and no other nuclear stain requires this.

Can I combine incorporation staining with surface markers?

With care. Acid denaturation damages many protein epitopes and most fluorescent proteins, so either use a gentler nuclease-based method or validate that each marker survives the protocol you use.

How long should the pulse be?

It depends what you are measuring. A short pulse labels cells synthesising at that moment and reports a rate; a long pulse labels everything that entered S phase during it and reports cumulative entry. State the length in the methods.

What does a par antibody report?

Poly-ADP-ribose, generated transiently at sites of DNA damage. It is a kinetic readout rather than a level, so an experiment needs a known inducer and a time course for a result to be interpretable.

Browse by service class

• Compare Gene synthesis on advertised prices